News

Subscription Revenue Growth, Expanding Global Presence, and Strategic Foundations for H2 Acceleration.

London, United Kingdom – 1 July 2025 – Rapid Nutrition PLC (Euronext Growth: ALRPD), an international HealthTech and wellness company, is pleased to provide a summary of its operational progress and strategic developments for the half-year period ended 30 June 2025.

Subscription Revenue Growth Supports Predictable Model

The Company’s flagship brand, SystemLS, continued to gain traction through its monthly subscription offering, delivering average monthly subscription growth of 34.5%, with later months exceeding 300%. This channel is increasingly contributing to revenue predictability and enhancing the Company’s ability to scale customer lifetime value.

Financial Clarity and Strategic Execution

The Company successfully completed the early conversion of all outstanding convertible bonds during H1, well ahead of the original schedule. This strengthens near-term financial clarity and supports a focused execution of its core growth strategy.

In parallel, strategic investment in inventory and infrastructure enabled the successful deployment of key initiatives across subscriptions, digital platforms, and international market development.

Expanding Global Market Visibility

Customer orders for SystemLS products have now been received in several new international markets, including Canada, the United Kingdom, Belgium, Switzerland, and Japan, reflecting growing global visibility for the brand.

In China, the Company continues to build momentum on the Douyin platform (TikTok China), leveraging KOL-driven livestreams and short-form video content with encouraging early conversion results.

Authentic Messaging Paired with Clinical Credibility

To further drive consumer connection, the Company launched a new campaign featuring wellness experts, focused on addressing everyday health challenges and promoting sustainable lifestyle change. This initiative is complemented by the brand’s participation in a large-scale clinical study in the United States, enhancing brand trust and scientific alignment.

Outlook and Investor Transparency

The Company notes that several initiatives undertaken in H1 — including investment in inventory and infrastructure — were foundational in nature, and are expected to support revenue flow-through in H2 as subscription volumes and international market activity scale.

To provide investors with greater insight, management has published a detailed Half-Year Corporate Update, now available on the Company’s website, alongside a dedicated China Market Operations Report, offering in-depth analysis of early traction in this key market.

Full Update Available

The full Half-Year 2025 Corporate Update and China Market Report are available in the Investor section of the Company’s website.
 

About Rapid Nutrition

Rapid Nutrition is a global HealthTech company dedicated to advancing wellness through evidence-based, personalized nutrition solutions. Leveraging advanced technologies, AI, and scientific research, the company is committed to optimizing nutrition, improving health outcomes, and fostering sustainable, healthier lifestyles worldwide.

Investor Relations Contact:
ir@rnplc.com

Disclaimer
This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and or otherwise that involve risks, uncertainties and assumptions that could cause Rapid Nutrition PLCs actual results and experience to differ materially from anticipated results and expectations expressed in these forward-looking statements. Rapid Nutrition PLC has in some cases identified forward-looking statements by using words such as "anticipates," "believes," "hopes," "estimates," "looks," "expects," "plans," "intends," "goal," "potential," "may," "suggest," and similar expressions. Rapid Nutrition PLC undertakes no obligation to release publicly the results of any revisions to any such forward-looking statements that may be made to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events, except as required by applicable law or regulation.

This media information does not constitute an offer to sell, or a solicitation of an offer to buy, any securities. This information does not constitute an offering prospectus within the meaning within the meaning of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 of June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Directive 2003/71 or a listing prospectus within the meaning of the listing rules of the Euronext Exchange or OTC Markets. The media release is in accordance with International Reporting Standard: Rule 12g3-2(b) under the Securities Exchange Act ('Rule 12g3-2(b)') permits non-U.S. companies with securities listed primarily on a Qualified Foreign Exchange to make publicly available to U.S investors in English the same information that is made publicly available in their home countries as an alternative to SEC reporting Exchange Act Rule 12g3-2(b).